Data sources used to determine the hazard rates for progression-free survival and overall survival associated with each clinical state, and the survival estimates derived from these publications for inclusion into the model.
收藏Figshare2015-12-03 更新2026-04-29 收录
下载链接：
https://figshare.com/articles/dataset/_Data_sources_used_to_determine_the_hazard_rates_for_progression_free_survival_and_overall_survival_associated_with_each_clinical_state_and_the_survival_estimates_derived_from_these_publications_for_inclusion_into_the_model_/1573146
下载链接
链接失效反馈官方服务：
资源简介：
*The distribution of patients flowing from nmCRPC to mCRPC that has not been treated with or not progressed on chemotherapy was determined based on Oudard et al 2009 [23].PSA, prostate-specific antigen; nmCRPC, non-metastatic castration-resistant prostate cancer; mCRPC, metastatic castration-resistant prostate cancer; NA, not applicable.Data sources used to determine the hazard rates for progression-free survival and overall survival associated with each clinical state, and the survival estimates derived from these publications for inclusion into the model.
创建时间：
2015-12-03
